We assume as a hypothesis a regulatory feed-forward loop between SREBP-2 and SND1 transcription and consequently, the overexpression of SND1 may disrupt cholesterol homeostasis and activate the SREBP-2 pathway in the hepatic cancer cells. Here, SREBF2 is linked to liver cancer.